CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
NICARDIPINE HYDROCHLORIDE
Approval overview CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER is listed in Drugs@FDA under application 019734 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient NICARDIPINE HYDROCHLORIDE Form and strength INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML) Sponsor CHIESI Submission history Latest submission status date: 2026-03-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER is listed in Drugs@FDA under application 019734 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NICARDIPINE HYDROCHLORIDE Form and strength INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML) Sponsor CHIESI Submission history Latest submission status date: 2026-03-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.